You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

AMINO ACIDS; DEXTROSE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for amino acids; dextrose and what is the scope of patent protection?

Amino acids; dextrose is the generic ingredient in forty-seven branded drugs marketed by Abbott, Hospira, Baxter Hlthcare, and Hospira Inc, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

One supplier is listed for this compound.

Summary for AMINO ACIDS; DEXTROSE
US Patents:0
Tradenames:47
Applicants:4
NDAs:15
Finished Product Suppliers / Packagers: 1
DailyMed Link:AMINO ACIDS; DEXTROSE at DailyMed
Pharmacology for AMINO ACIDS; DEXTROSE
Drug ClassAmino Acid

US Patents and Regulatory Information for AMINO ACIDS; DEXTROSE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbott AMINOSYN II 4.25% IN DEXTROSE 25% IN PLASTIC CONTAINER amino acids; dextrose INJECTABLE;INJECTION 019713-005 Sep 9, 1988 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Abbott AMINOSYN II 4.25% IN DEXTROSE 25% IN PLASTIC CONTAINER amino acids; dextrose INJECTABLE;INJECTION 019504-002 Nov 7, 1986 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Abbott AMINOSYN II 3.5% IN DEXTROSE 25% IN PLASTIC CONTAINER amino acids; dextrose INJECTABLE;INJECTION 019505-002 Nov 7, 1986 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Baxter Hlthcare CLINIMIX 2.75/25 SULFITE FREE IN DEXTROSE 25% IN PLASTIC CONTAINER amino acids; dextrose INJECTABLE;INJECTION 020734-005 Sep 29, 1997 RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Hospira AMINOSYN II 4.25% IN DEXTROSE 20% IN PLASTIC CONTAINER amino acids; dextrose INJECTABLE;INJECTION 019681-005 Nov 1, 1988 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Baxter Hlthcare TRAVASOL 4.25% IN DEXTROSE 5% IN PLASTIC CONTAINER amino acids; dextrose INJECTABLE;INJECTION 019520-006 Sep 23, 1988 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

AMINO ACIDS; DEXTROSE Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for Amino Acids and Dextrose

Introduction

Amino acids and dextrose are crucial components in various industries, including pharmaceuticals, food and beverage, and medical nutrition. Understanding their market dynamics and financial trajectories is essential for stakeholders looking to invest or expand in these sectors.

Amino Acids Market Dynamics

Global Market Outlook

The global amino acid market, particularly the D-amino acid segment, is experiencing significant growth. The market was valued at US$ 178.5 million in 2022 and is projected to grow at a CAGR of 5.0% from 2023 to 2031, reaching US$ 277.4 million by the end of 2031[3].

Demand Side Trends

The demand for D-amino acids is driven by several factors:

  • Pharmaceutical Sector: The rise in demand for peptide-based drugs is a prominent driver. D-amino acids are used in the production of various medications, including nicotinamide acetylcholine receptors, calcium channels, and anti-epileptic medicines[3].
  • Nutritional Supplements: Increasing awareness about the role of D-amino acids in healthy body functioning is fostering market growth[3].
  • Biosynthesis and Research: Expansion in the biosynthesis sector and significant contributions from research centers and laboratories are also driving the market[3].

Regional Analysis

  • Asia Pacific: This region accounts for a significant market share due to the presence of a large number of manufacturers and processors in the pharmaceutical sector. Countries like China and Japan are expected to boost demand due to modernization and growth in pharmaceutical production[3].
  • North America and Europe: These regions are also key markets, with the U.S. expected to record significant growth due to advancements in research and manufacturing techniques related to D-amino acids[3].

Challenges and Opportunities

  • Competition: The market is dominated by large corporations, leading to intense rivalry. Companies are engaging in R&D, mergers, acquisitions, and partnerships to strengthen their market position[3].
  • Diverse Applications: D-amino acids are used in various sectors, including food and beverage, cosmetics, and biotechnology, which is bolstering market statistics[3].

Dextrose Market Dynamics

Global Market Outlook

The global dextrose market was valued at around USD 5.7 billion in 2022 and is estimated to register a CAGR of 7.9% between 2023 and 2032, reaching USD 12.2 billion by 2032[4].

Demand Side Trends

  • Food and Beverage Industry: Dextrose is widely used as a sweetener in various food and beverage products, including baked goods, confectionery, and processed foods. The increasing demand for health and wellness products is driving the market[4].
  • Pharmaceutical Industry: Dextrose is used to produce intravenous solutions that provide a source of glucose and energy to patients in medical settings[4].
  • Sports Nutrition: Although the demand in sports nutrition declined during the pandemic, it is expected to recover as consumer behavior normalizes[4].

Product Segmentation

  • Dextrose Monohydrate: Held a majority market value of USD 2.1 billion in 2022. It is versatile and used in food and beverage processing, pharmaceuticals, and medical nutrition[4].
  • Dextrose Anhydrous: Known for its long shelf life, sweet taste, and ease of use, storage, and transportation. It is increasingly used in food products and by athletes to replenish muscle glycogen levels[1].

Distribution Channels

  • Online Retail: Held a dominant market share in 2022 and is anticipated to grow at a 7.1% CAGR till 2032, driven by the rise of online shopping and e-commerce platforms[4].

Financial Trajectory

Amino Acids

The financial trajectory of the D-amino acid market is promising, with a projected CAGR of 5.0% from 2023 to 2031. Key factors driving this growth include:

  • Increasing Demand in Pharmaceuticals: The growing need for peptide-based drugs and other medical applications is expected to drive revenue[3].
  • Expansion in Biosynthesis and Research: Partnerships with research laboratories and advancements in biosynthesis are contributing to market expansion[3].

Dextrose

The dextrose market is expected to grow significantly, with a projected CAGR of 7.9% from 2023 to 2032. Key financial drivers include:

  • Growing Demand in Food and Beverage: The increasing use of dextrose as a sweetener in various food products is driving market growth[4].
  • Recovery in Sports Nutrition: As consumer behavior normalizes post-pandemic, the demand in sports nutrition is expected to recover, contributing to overall market growth[4].

Challenges and Restraints

Amino Acids

  • Competition: The market is highly competitive, with large corporations vying for market share. This competition can lead to pricing pressures and the need for continuous innovation[3].

Dextrose

  • Health Concerns: Dextrose can lead to several health issues, including hyperglycemia, increased body fat, and hypoglycemia. These concerns can affect consumer demand and regulatory oversight[1].
  • Pandemic Impact: The pandemic caused fluctuations in demand, particularly in industries like sports nutrition. However, as the pandemic subsides, these sectors are expected to recover[4].

Key Takeaways

  • Amino Acids: The D-amino acid market is driven by pharmaceutical demand, nutritional supplements, and biosynthesis. It is expected to grow at a CAGR of 5.0% from 2023 to 2031.
  • Dextrose: The dextrose market is driven by the food and beverage industry, pharmaceuticals, and sports nutrition. It is expected to grow at a CAGR of 7.9% from 2023 to 2032.
  • Regional Growth: Asia Pacific and North America are key regions for both markets, driven by industrial growth and research advancements.
  • Challenges: Both markets face challenges such as competition, health concerns, and pandemic-related disruptions.

FAQs

1. What are the primary drivers of the D-amino acid market? The primary drivers include the rise in demand for peptide-based drugs, increasing awareness about nutritional supplements, and expansion in the biosynthesis sector[3].

2. How is the dextrose market segmented? The dextrose market is segmented by product (dextrose monohydrate, dextrose anhydrous, liquid dextrose), application (food and beverage, pharmaceuticals, medical nutrition), and distribution channel (direct sales, retail sales, online retail, etc.)[4].

3. What are the health concerns associated with dextrose? Dextrose can lead to health issues such as hyperglycemia, increased body fat, hypoglycemia, and other symptoms like increased thirst, swelling, and nausea[1].

4. How has the pandemic impacted the dextrose market? The pandemic caused fluctuations in demand, with increased demand in food and pharmaceutical industries but a decline in sports nutrition. As the pandemic subsides, the market is expected to recover[4].

5. What is the projected CAGR for the D-amino acid and dextrose markets? The D-amino acid market is projected to grow at a CAGR of 5.0% from 2023 to 2031, while the dextrose market is expected to grow at a CAGR of 7.9% from 2023 to 2032[3][4].

Cited Sources

  1. Persistence Market Research - Dextrose Anhydrous Market: Global Industry Analysis and Forecast[1]
  2. American Society of Health-System Pharmacists - Strategies for Successful Parenteral Nutrition Order Writing[2]
  3. Transparency Market Research - D-amino Acid Market Size, Share, Analysis & Forecast 2031[3]
  4. Global Market Insights - Dextrose Market Size, Share & Forecast Analysis Report – 2032[4]

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.